Algorae Pharmaceuticals Limited

DB:LHI1 Stock Report

Market Cap: €9.4m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Algorae Pharmaceuticals Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

David Hainsworth

Chief executive officer

AU$40.0k

Total compensation

CEO salary percentage100.0%
CEO tenure1.8yrs
CEO ownership1.2%
Management average tenure1yrs
Board average tenure1.8yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has David Hainsworth's remuneration changed compared to Algorae Pharmaceuticals's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023n/an/a

-AU$2m

Sep 30 2023n/an/a

-AU$2m

Jun 30 2023AU$40kAU$40k

-AU$2m

Compensation vs Market: David's total compensation ($USD27.09K) is below average for companies of similar size in the German market ($USD505.12K).

Compensation vs Earnings: Insufficient data to compare David's compensation with company performance.


CEO

David Hainsworth (50 yo)

1.8yrs

Tenure

AU$40,000

Compensation

Mr. David Richard Hainsworth is an Associate Director with Alignment Capital, principally focused on the origination and execution of primarily Australian Stock Exchange based capital market transactions w...


Leadership Team

NamePositionTenureCompensationOwnership
David Hainsworth
CEO & Executive Chairmanno dataAU$40.00k1.19%
A$ 112.0k
Daya Uka
Chief Financial Officer5.3yrsAU$153.71kno data
Belinda Bartolo
Chief Operations Officer2.6yrsAU$182.95kno data
Carolyn Sue
Member of Medical Advisory Board & Chief Medical Officer of NTCELLless than a yearAU$50.00k0.067%
A$ 6.3k
James Mckenna
Chief Scientific Officer1.1yrsno datano data
Leah Pieris
Company Secretaryless than a yearno datano data
Jennifer Voon
Company Secretaryno datano datano data

1.0yrs

Average Tenure

Experienced Management: LHI1's management team is not considered experienced ( 1 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
David Hainsworth
CEO & Executive Chairman1.8yrsAU$40.00k1.19%
A$ 112.0k
Carolyn Sue
Member of Medical Advisory Board & Chief Medical Officer of NTCELLno dataAU$50.00k0.067%
A$ 6.3k
Bradley Latham
Non-Executive Directorless than a yearno data1.19%
A$ 112.0k
Bradley Dilkes
Non-executive Director1.8yrsAU$33.33k1.19%
A$ 112.0k

1.8yrs

Average Tenure

55.5yo

Average Age

Experienced Board: LHI1's board of directors are not considered experienced ( 1.8 years average tenure), which suggests a new board.